Skip to main content
. 2019 Apr 8;74(11):1753–1760. doi: 10.1093/gerona/glz088

Figure 2.

Figure 2.

Kaplan–Meier plots demonstrating the relationship between biomarker positivity for combined biomarker positivity of amyloid-β and neurodegeneration (A/N) at study baseline (top section) and at endpoint (bottom section) with time (years) to progression to amnestic mild cognitive impairment in cognitively normal individuals.